Evidence map›Paper›PMID 31182618›Full record

ArticleInfection and immunity2019

Intradermal Synthetic DNA Vaccination Generates

Lumena Louis, Megan Clark, Megan C Wise, Nelson Glennie, Andrea Wong, Kate Broderick, Jude Uzonna, David B Weiner, Phillip Scott

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 27 citations in OpenAlex.

  1. Single-Cell Profiling Identifies Skin-Resident Memory CD4European journal of immunology · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Live attenuated-nonpathogenicFrontiers in microbiology · 2024
    Review
  8. Review
  9. A New Strategy for Mapping Epitopes of LACK and PEPCK Proteins ofInternational journal of molecular sciences · 2023
    Article
  10. Review
  11. Article
  12. Frontiers in immunology · 2022
    Article
  13. Article
  14. Frontiers in immunology · 2021
    Article
  15. Review
  16. Article
  17. Review
  18. Microorganisms · 2020
    Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Lumena LouisDepartment of Pathology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Megan ClarkDepartment of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Megan C WiseInovio Pharmaceuticals, Plymouth Meeting, Pennsylvania, USA.
Nelson GlennieDepartment of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Andrea WongDepartment of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Kate BroderickInovio Pharmaceuticals, Plymouth Meeting, Pennsylvania, USA.
Jude UzonnaDepartment of Immunology, College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
David B WeinerDepartment of Pathology, University of Pennsylvania, Philadelphia, Pennsylvania, USA dweiner@wistar.org pscott@vet.upenn.edu.
Phillip ScottDepartment of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA dweiner@wistar.org pscott@vet.upenn.edu.
University of Pennsylvania · USInovio Pharmaceuticals (United States) · USThe Wistar Institute · USUniversity of Manitoba · CA

Funding

VMD-PhD Training in Infectious Disease-Related ResearchT32AI070077 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI Michael Lee Atchison · 2008 to 2026
$3.5M
Resident Memory T cells in LeishmaniasisR01AI125265 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI SCOTT, PHILLIP · 2016 to 2020
$2.0M
NIAID NIH HHS R01 AI125265NIAID NIH HHS T32 AI070077
6 · The paper itself

Abstract

Vaccination remains one of the greatest medical breakthroughs in human history and has resulted in the near eradication of many formerly lethal diseases in many countries, including the complete eradication of smallpox. However, there remain a number of diseases for which there are no or only partially effective vaccines. There are numerous hurdles in vaccine development, of which knowing the appropriate immune response to target is one of them. Recently, tissue-resident T cells have been shown to mediate high levels of protection for several infections, although the best way to induce these cells is still unclear. Here we compare the ability to generate skin-resident T cells in sites distant from the immunization site following intramuscular and intradermal injection using optimized synthetic DNA vaccines. We found that mice immunized intradermally with a synthetic consensus DNA HIV envelope vaccine by electroporation (EP) are better able to maintain durable antigen-specific cellular responses in the skin than mice immunized by the intramuscular route. We extended these studies by delivering a synthetic DNA vaccine encoding

Indexed as

VaccinationAnimalsFemaleHEK293 CellsHumansLeishmania majorLeishmaniasis, CutaneousMiceMice, Inbred C57BLProtozoan VaccinesSkinT-LymphocytesVaccines, DNAProtozoan VaccinesVaccines, DNADNA vaccinesintradermalLeishmaniaPEPCKSEP

Identifiers

PMID31182618
PMCPMC6652766
OpenAlexW2964236653

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.